findmyKOL
Clinical trialNCT03208231CompletedPhase 1/PHASE2Interventional

Evaluating the Safety and Antiviral Activity of Monoclonal Antibody VRC01 in Infants With HIV Receiving Combination Antiretroviral Therapy

SponsorNational Institute of Allergy and Infectious Diseases (NIAID)Enrollment61HIV Infections
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study was to evaluate the safety and antiviral activity to promote clearance of HIV-1 infected cells of VRC01 in infants with HIV beginning combination antiretroviral therapy (cART).
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Botswana
  • Molepolole Crs

    Molepolole, Kweneng District, Botswana

  • Gaborone Crs

    Gaborone, South-East District, Botswana

Brazil
  • Hosp. Geral de Nova Igaucu Brazil Nichd Crs

    Rio de Janeiro, Brazil

  • Hospital Federal Dos Servidores Do Estado Nichd Crs

    Rio de Janeiro, Brazil

Malawi
  • Malawi Crs

    Lilongwe, Central Region, Malawi

  • Blantyre Crs

    Blantyre, Malawi

Zimbabwe
  • Harare Family Care Crs

    Harare, Zimbabwe

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Combination Antiretroviral TherapyVRC01
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
6 Aug 2018
Primary completion
16 Jun 2020
Completion
11 Feb 2021
Last update posted
24 May 2023
Registered enrollment
61
Registry id
NCT03208231
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.